Michael Forer
Partner at Rosetta Capital Ltd.
About
Michael Forer co-founded Rosetta in 2001 and has over 20 years of experience in the life science sector as an entrepreneur, advisor, and investor, beginning at Rothschild Asset Management. As a partner at Auven Therapeutics, he led the Spirogen investment (later sold to AstraZeneca) and the spin-out of ADC Therapeutics. He holds a BA in economics, a diploma in international business, and an LLB from the University of British Columbia, and articled at the predecessor firm of Norton Rose Canada.
Invests in
Biotech
Investments
Led
Spirogen
Board seats
AditechKDev InvestmentsResonant MedicalRose Pharma
Investor
ADC Therapeutics
As listed on the firm's website.
Colleagues at Rosetta Capital Ltd.
Donovan Leung
Investment Manager at Rosetta Capital Ltd.
Graham Fagg
Partner Emeritus at Rosetta Capital Ltd.
Jonathan Hepple
Managing Partner at Rosetta Capital Ltd.
Ken Macleod
Partner at Rosetta Capital Ltd.
Matthew James
Chief Financial Officer at Rosetta Capital Ltd.
Namrata Turaga
Investment Manager at Rosetta Capital Ltd.